Product Information

DEXTROAMPHETAMINE ER 10 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $1.0065 per EA under NDC 45963030409. Its NADAC has been published 627 times since Aug 20, 2014.

FDA first approved this application on Nov 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEXTROAMPHETAMINE ER 10 MG CAP

dextroamphetamine sulfate
$1.0065per EA
DEA Schedule CII

Strength

10 mg/1

NDC

45963030409

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DEXTROAMPHETAMINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203901

FDA Approved

11/30/2012

TE Code

AB

On Market Since

6/19/2014

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMPHETAMINE ER 10 MG CAP has been published 627 times since Aug 20, 2014, and over the history we have for it it has declined 72.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0065 per EA
All-time high$4.0034 (Jul 15, 2015)
All-time low$0.5626 (Mar 20, 2024)
52-week high$1.1212
52-week low$0.8895
Median price$1.4248
Average price$1.7507
Largest weekly change+65.4% (Mar 18, 2020)
Weeks tracked627
Tracking sinceAug 20, 2014

Price History

1W

+1.2%

1M

+1.2%

3M

-1.2%

6M

+0.9%

1Y

+13.2%

3Y

-6.0%

5Y

-31.3%

All

-72.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROAMPHETAMINE ER 10 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPHETAMINE ER 10 MG CAP, manufactured by Actavis Pharma, Inc., is $1.0065 per EA (NDC 45963030409), effective Aug 19, 2026.

How has the price of DEXTROAMPHETAMINE ER 10 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXTROAMPHETAMINE ER 10 MG CAP has declined 72.8%. It has been tracked across 627 weekly CMS publications since Aug 20, 2014.

What are the highest and lowest recorded NADAC prices for DEXTROAMPHETAMINE ER 10 MG CAP?

Since Aug 20, 2014, the NADAC for DEXTROAMPHETAMINE ER 10 MG CAP has ranged from a low of $0.5626 (Mar 20, 2024) to a high of $4.0034 (Jul 15, 2015), with a median of $1.4248 per EA.

Are there cheaper alternatives to DEXTROAMPHETAMINE ER 10 MG CAP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXTROAMPHETAMINE ER 10 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMPHETAMINE ER 10 MG CAP?

DEXTROAMPHETAMINE ER 10 MG CAP (NDC 45963030409) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.